TabletAnti HIV

Tenofovir & Emtricitabine Tablets

Tenofovir Disoproxil Fumarate + Emtricitabine · Nucleoside/nucleotide reverse transcriptase inhibitor combination

TabletAnti HIV

Tenofovir & Emtricitabine TabletsProspero Healthcare

A fixed-dose tablet combining tenofovir disoproxil fumarate and emtricitabine, two reverse transcriptase inhibitors. It is used in antiretroviral therapy for HIV-1 infection and for pre-exposure prophylaxis.

Uses

HIV-1 infection
HIV pre-exposure prophylaxis

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Tenofovir Disoproxil Fumarate + Emtricitabine
Available strengthsIndicative: 300 mg + 200 mg
Dosage form: Tablet
Therapeutic category: Anti HIV Anti Viral Anti Hepatitis
Therapeutic class: Nucleoside/nucleotide reverse transcriptase inhibitor combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category